How should the dose of pharmacological cholesterol- lowering treatment be determined in CKD patients?
Guidelines for the general population recommend that (among patients receiving statin treatment), the dose of statin is titrated to achieve the target level of LDL-C, which in turn is determined by each patient's presumed coronary risk. This approach is widely accepted, although it has never been shown to lead to clinical benefit in a RCT.